A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2006
12/28/2006	WO2006136714A1 Novel compounds of the family of iminosugars, uses thereof for treating lysosomal diseases, and method for preparing same
12/28/2006	WO2006136606A2 Oxindole derivatives
12/28/2006	WO2006136563A1 2-substituted benzimidazoles
12/28/2006	WO2006136562A1 Heterocyclylaminoalkyl substituted benzimidazoles
12/28/2006	WO2006136561A1 1- ( 2-amino-3- (substituted alkyl)-3h-benzimidazoiylmethyl) -3-subtituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus
12/28/2006	WO2006136553A1 Imidazolinone and hydantoine derivatives as novel inhibitors of histone deacetylase
12/28/2006	WO2006136552A2 Process for the production of intermadiates for the preparation of tricyclic benzimidazoles
12/28/2006	WO2006136530A1 Halogenated pyrazolo [1,5-a]pyrimidines, processes, uses as gaba-a receptors ligand, compositions and intermediates
12/28/2006	WO2006136502A1 ( 6-FLU0R0-BENZ0[l, 3] DIOXOLYL) -MORPHOLIN-4-YL-METHANONES AND THEIR USE AS CBl LIGANDS
12/28/2006	WO2006136462A1 Benzofuranone derivatives as nonsteroidal progesterone receptor modulators
12/28/2006	WO2006136461A2 Non-steroidal progesterone receptor modulators
12/28/2006	WO2006136454A2 Use of inhibitors of n-methyl transferases for the therapy of parkinson's disease
12/28/2006	WO2006136442A1 Pyrimidine derivatives for the treatment op gaba b mediated nervous system disorders
12/28/2006	WO2006136408A2 Process for preparing pure amorphous rosuvastatin calcium
12/28/2006	WO2006136407A1 Process for preparing amorphous rosuvastatin calcium free of impurities
12/28/2006	WO2006136402A1 Thienopyrimidines for pharmaceutical compositions
12/28/2006	WO2006136309A1 Cripowellins and synthetic derivatives thereof used as medicaments
12/28/2006	WO2006136305A1 SUBSTITUTED PYRR0LIDIN-2-0NES , PIPERIDIN-2-0NES AND ISOTHIAZOLIDINE-1, 1-DIOXIDES, THEIR USE AS KVl .5 POTASSIUM CHANNEL BLOCKERS AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM
12/28/2006	WO2006136304A1 Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them
12/28/2006	WO2006136302A1 Solid pharmaceutical preparation containing (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chroman
12/28/2006	WO2006136284A1 Pharmaceutical composition comprising a 1-(3-chlorophenyl)-3-alkylpiperazine for treating apetite disorder
12/28/2006	WO2006136245A1 Substituted spiro-compounds and the use thereof for producing medicaments
12/28/2006	WO2006136232A1 Bicalutamide adsorbates, process for preparing same, and pharmaceutical compositions thereof
12/28/2006	WO2006136223A1 Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
12/28/2006	WO2006136175A2 Pharmaceutical compositions comprising tacrolimus and a cyp3a4 inhibitor
12/28/2006	WO2006136101A1 Glucagon like peptide-1 receptor (glp-1r) regulators, preparation methods and uses
12/28/2006	WO2006136081A1 A composition containing coenzyme q10 for treating dermatopathy, and its preparation method
12/28/2006	WO2006136063A1 Aporphine and secoaporphine compounds for treatment of diabetes
12/28/2006	WO2006136008A1 Salicylic acid hydrazones as inhibitors of the erk mapkinase pathway and for the treatment of cancer
12/28/2006	WO2006136005A1 Purine derivatives and their use for treatment of autoimmune diseases
12/28/2006	WO2006136004A1 Inhibition of atp-mediated, p2x7 dependent pathways by pyridoxal-5-phosphaste and vitamin b6 related compounds
12/28/2006	WO2006135993A1 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for treating hepatitis c.
12/28/2006	WO2006135978A1 Antiviral compounds and methods
12/28/2006	WO2006135973A1 Small molecule glycosaminoglycan mimetics
12/28/2006	WO2006135949A2 Tumour treatment with gliotoxin derivatives
12/28/2006	WO2006125132A3 Aerosolized fluoroquinolones and uses thereof
12/28/2006	WO2006124902A3 Synthesis of salinosporamide a and analogues thereof
12/28/2006	WO2006123031A3 Pharmaceutical composition comprising an oleaginous ointment and vitamin d or the derivatives thereof in solubilised form
12/28/2006	WO2006122014A3 Bicyclic derivatives as modulators of ion channels
12/28/2006	WO2006121648A3 Method for preparation of optionally 2-substituted 1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acids
12/28/2006	WO2006119499A3 Use of phycotoxins in veterinary applications
12/28/2006	WO2006117461A3 Alkyl-, alkenyl- et alkynyl carbamate derivatives, the preparation and therapeutic use thereof
12/28/2006	WO2006117299A9 Novel crystalline forms of tiotropium bromide
12/28/2006	WO2006117299A2 Novel crystalline forms of tiotropium bromide
12/28/2006	WO2006113731A3 Bone marrow-derived neurogenic cells and uses thereof
12/28/2006	WO2006110753A3 Deodorant body wash with lotion
12/28/2006	WO2006110555A3 Cleansing foaming sunscreen lotion
12/28/2006	WO2006108670A3 Use of cd25 antibodies in immunotherapy
12/28/2006	WO2006107273A8 Compounds having progestogenic activity and their use
12/28/2006	WO2006106358A3 Use of nk-3 receptor antagonists for the treatment of nausea and vomiting
12/28/2006	WO2006106344A3 Abuse resistant capsules
12/28/2006	WO2006105222A3 Carboxamide inhibitors of tgfb
12/28/2006	WO2006104870A3 Methods of treating benign prostatic hyperplasia or lower urinary track symptoms by using pde 5 inhibitors
12/28/2006	WO2006103277A3 2 , 4 , 5-substituted piperidines as renin inhibitors
12/28/2006	WO2006102899A3 Oxaprozin or closely related compound for the treatment and prevention of
12/28/2006	WO2006102898A3 Oxaprozin or a closely related compound for the treatment of eczema
12/28/2006	WO2006102112A3 Prokineticin 1 receptor
12/28/2006	WO2006101521A3 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
12/28/2006	WO2006099480A3 Stress proteins and peptides and methods of use thereof
12/28/2006	WO2006099314A8 Use of methylnaltrexone and related compounds to treat constipation in terminally ill patients
12/28/2006	WO2006098918B1 Substituted gamma lactams as therapeutic agents
12/28/2006	WO2006097617A3 Novel dihydropyrimidine derivatives and their use as anti-cancer agents
12/28/2006	WO2006094640A3 Roflumilast and integrin inhibitor combination and method of treatment
12/28/2006	WO2006094292A3 Thienopyridine compounds, and methods of use thereof
12/28/2006	WO2006093719A8 An efficient and stereoselective process for large scale synthesis of 3-(r)-3- (2,3-dihydrobenzofuran-5-yl)-1,2,3,4- tetrahydropyrrolo{3,4-b}quinolin-9-one
12/28/2006	WO2006092032B1 PHARMACEUTICAL COMPOSITIONS CONTAINING 1-METHYL-3,6,7,8-TETRAHYDROPIRAZOLO[3,4-b]PIRROLO[4,3-d]PYRIDINE-6,8-DIONE DERIVATIVES, USE, AND PROCESS FOR PREPARING THEM
12/28/2006	WO2006091767A3 Methods, compositions and articles of manufacture for contributing to the treatment of solid tumors
12/28/2006	WO2006089973A3 Dosage form containing oxycodone and naloxone
12/28/2006	WO2006087420A3 A method for treating heart failure
12/28/2006	WO2006087419A3 A method for administering levosimendan
12/28/2006	WO2006086865A3 Combi-preparation of nucleoside and non-nucleoside reverse transcriptase inhibitors for the treatment of hiv infections
12/28/2006	WO2006086422A3 Compositions and methods for inhibiting an isoform of human manganese superoxide dismutase
12/28/2006	WO2006086130A3 Process for crystallizing lactose particles for use in pharmaceutical formulations
12/28/2006	WO2006083645A3 Formulations and dosing regimen for ppar-alpha modulators
12/28/2006	WO2006083508A3 Combinations of superoxide dismutase mimetics and nonsteroidal analgesic/anti-inflammatory drugs
12/28/2006	WO2006082409A8 Tricyclic cytoprotective compounds
12/28/2006	WO2006081252A3 Use of 1-benzyl-1-hydr0xy-2, 3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds as analgesics
12/28/2006	WO2006081251A3 Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1-3-dione
12/28/2006	WO2006077429A8 Anthelmintic composition
12/28/2006	WO2006076620A3 Bendamustine pharmaceutical compositions for lyophilisation
12/28/2006	WO2006076568A3 Thiazolopyridines as cannabinoid receptor modulators
12/28/2006	WO2006076169A3 Treatment or prevention of genital viral infections with immunomodulator compounds
12/28/2006	WO2006074397A3 Cripto binding molecules
12/28/2006	WO2006067577A3 Stable non-dihydrate azithromycin oral suspensions
12/28/2006	WO2006061700A3 Rapid disintegrating taste masked compositions and a process for its preparations
12/28/2006	WO2006060381A3 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library
12/28/2006	WO2006060211A3 Pyrazole derivatives for the treatment of sexual dysfunction
12/28/2006	WO2006056873A3 Therapeutic pyrazolo[3,4-b] pyridines and indazoles
12/28/2006	WO2006055463A3 2-amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
12/28/2006	WO2006050054A3 Compounds and methods of use thereof
12/28/2006	WO2006049941A3 Diaryl ureas as cb1 antagonists
12/28/2006	WO2006044645A3 Sulfamoyl benzamides and methods of their use
12/28/2006	WO2006042733A3 Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same
12/28/2006	WO2006041409A8 Medical solution, method for producing and use thereof
12/28/2006	WO2006040615A3 Differenciation of stem cells for therapeutic use
12/28/2006	WO2006030323A3 Compounds that inhibit replication of human immunodeficiency virus
12/28/2006	WO2006028961A3 Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators
12/28/2006	WO2006024958A3 Cannabinoid compositions and methods of use thereof
12/28/2006	WO2006020680A3 Heterocyclic compounds as pharmaceutical agents
12/28/2006	WO2006020358A3 Novel biphenyl compounds and their use

1 ... 3944 3945 3946 3947 3948 3949 3950 3951 3952 3953 3954 3955 3956 3957 3958 3959 3960 3961 3962 3963 3964 ... 7860